Clinical Trial Update: Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vinorelbine + cisplatin versus no further therapy after surgical resection in non-small cell lung cancer; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Vinorelbine + Cisplatin

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED